MALIBU AJL13341-GB

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional,user faci report with the FDA on 2016-06-15 for MALIBU AJL13341-GB manufactured by Arjohuntleigh Polska Sp. Z O.o..

Event Text Entries

[47396352] (b)(4). An investigation was carried out into this complaint. When reviewing similar reportable events for malibu we have found other similar cases where the chair did not securely attach to the lifting arm. We have been able to establish that there is no complaint trend concerning these kinds of events. The patient was being transferred to the bathroom using a bath chair and a transfer trolley. After being cleaned up post commode the seat was moved into position to begin lift into bath. The hand control was used to raise the chair. On attempting to remove the transfer trolley, the patient and the chair frame fell to the floor and in that way contributed to the event. No injury occurred. The device has been tested by technician - function test showed that the device was working to its specification. No repair or adjustment has been done. An arjohuntleigh technician tested bath function focusing on transfer procedure. The seat has been moved up to lift arm using hand control. The handset was used to raise chair frame until the latch was correctly located. The transfer trolley was removed and transfer into the bath- test was completed without problems (test was performed with and without load). No malfunctions were found that could have caused or contributed to the event. The product's instruction for use is attached with each device, ifu includes information how to properly and safely use the device: "always make sure that: all lifting/transporting equipment is in good condition, follow the instructions for all equipment; chair seats, shower tables etc. , are fastened and all screws tightened; the wheels always are locked during resident handling, except during transportation". The instruction for use also includes warnings concerning the locking mechanism of the lifting unit and seat and transferring chair: "before using the transfer chair, make sure it is safely attached to the lift arm and that the locking mechanism is thoroughly locked. "; "when using the lift arm with transfer chair and/or using the height adjustable bathtub, the operator must assure that there are no obstructions or persons in the immediate vicinity that could impede its movement. ". Moreover the ifu provides instructions how to properly connect chair to the lifting unit: "connecting: set the bath tub in its lowest position by press and hold the lowering of tub button; press lift out of tub; grip the transfer chair and place the attachment of the chair and hook up the chair to the lift arm; raise the lift arm by press the hold the lift into tub button, do that the transfer chair is hooked up on the lift arm and the chassis gets clear of the floor; make sure that hooks (a) are securely attached to the lift arm and that the safety catch (b) is in place. Also the ifu contains the warning: "before transporting residents on the transfer chair with chassis always make sure that the transfer chair is safely attached to the chassis i. E. That the spring loaded catch has clicked into its locked position. " information provided in the complaint indicates that the chair failed to be securely attached onto the lifting arm hook. The bath and transfer trolley have been tested and no failure was found. There was no possibility to recreate the event. The bath was in good working condition. According to the above the bath was found to have been to specification when the event took a place. It can be established that bath was being used for patient handling but it appears it contributed to the event likely due to a use error. Please note, that if the caregiver follows every guideline given in instruction for use, there is a really low possibility of any potentially risky situation to occur.
Patient Sequence No: 1, Text Type: N, H10


[47396353] There was initially reported to arjohuntleigh representative that:. "patient was being transfer to bathroom using bath chair and transfer trolley. After being cleaned up post commode the seat was moved into position to begin lift into bath. The hand control was used to raise the chair. On attempting to remove the transfer trolley, the patient and the chair frame fell to the floor. No severe injuries reported. "
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3007420694-2016-00112
MDR Report Key5725423
Report SourceHEALTH PROFESSIONAL,USER FACI
Date Received2016-06-15
Date of Report2016-05-17
Date of Event2016-05-16
Date Facility Aware2016-05-17
Report Date2016-06-15
Date Reported to FDA2016-06-15
Date Reported to Mfgr2016-06-15
Date Mfgr Received2016-05-17
Device Manufacturer Date2007-09-03
Date Added to Maude2016-06-15
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMRS PAMELA WRIGHT
Manufacturer Street12625 WETMORE, STE 308
Manufacturer CitySAN ANTONIO, TX 78247
Manufacturer CountryUS
Manufacturer Postal78247
Manufacturer Phone2103170412
Manufacturer G1ARJOHUNTLEIGH POLSKA SP. Z O.O.
Manufacturer StreetUL. KS. PIOTRA WAWRZYNIAKA 2
Manufacturer CityKOMORNIKI, 62-052
Manufacturer CountryPL
Manufacturer Postal Code62-052
Single Use3
Remedial ActionNO
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameMALIBU
Generic NameILM
Product CodeILM
Date Received2016-06-15
Model NumberAJL13341-GB
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Age8 YR
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerARJOHUNTLEIGH POLSKA SP. Z O.O.
Manufacturer AddressUL. KS. PIOTRA WAWRZYNIAKA 2 KOMORNIKI, 62-052 PL 62-052


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2016-06-15

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.